Melanocytes are potential immunocompetent cells: Evidence from recognition of immunological characteristics of cultured human melanocytes

Pigment Cell Research

Volumn 15, Issue 6, 2002, Pages 454-460

  Lu, Yan ^a   Zhu, Wen Yuan ^a   Tan, Cheng ^a   Yu, Ge Hua ^b   Gu, Jing Xiong ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Department of Radiation Medicine   (China)

Author keywords

Antigen presenting cells; CD40; CD40 ligand; Cytotoxic T lymphocyte; Interferon ; Melanocyte

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CD40 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; HUMAN; IMMUNOCOMPETENCE; IMMUNOLOGY; IMMUNOPHENOTYPING; MELANOCYTE; METABOLISM; SECRETION;

ADULT; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; HUMANS; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-12; MELANOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036891313     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2002.02065.x     Document Type: Article

References (59)

1. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP. The Pigmentary System - Physiology and Pathophysiology. New York: Oxford University Press; 1998. pp. 305-472
2. Levine N. Pigmentation and Pigmentary Disorders. CRC Press: Boca Raton, FL; 1993. pp. 3-95
3. Norris DA, Kissinger RM, Naughton GM, Bystryn JC. Evidence for immunologic mechanisms in human vitiligo: Patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol 1988;90:738-789
4. Merimsky OY, Shoenfeld E, Baharav M, Altomonte S, Chaitchik M, Maio S, Ferrone PF, Melanoma-associated hypopigmentation: Where are the antibodies? Am J Clin Oncol 1996;19:613-618
5. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plean E, Lethe B, Coulie P, Boon T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993;178:489-495
6. Coulie PG, Brichard V, Van Pel A, Wolfel T, Schneider J, Traversari C, Mattei S, De Plean E, Lurquin C, Szikora JP. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994; 180:35-42
7. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins P, Rivoltini L, Yannelli J, Appella E, Rosenberg S. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 1994;180:347-352
8. Le Gal FA, Avril MF, Bosq J, Lefebvre P, Deschemin JC, Andrieu M, Dote MX, Gullier JG. Direct evidence to support the role of antigen-specific CD8+ T cells in melanoma-associated vitiligo. J Invest Dermatol 2001;117:1464-1470
9. Badri AM, Todd PM, Garioch JE, Gudgeon DS, Goudie RB. An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol 1993;170:149-155
10. Le Poole IC, van den Wijngaard RM, Westerhof W, Dutrieux RP, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996;148:1219-1228
11. Van den Wijngarrd R, Wankowicz-kalinska A, Le Poole C, Tigges B, Westerhof W, Das P. Local immune response in skin of generalized vitiligo patients: Destruction of melanocytes is associated with the prominent presence of CLA + T cells at the perilesional site. Lab Invest 2000;80:1299-1309
12. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-332
13. Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, Kenyon K, Davis MM, Riddell SR, Greenberg PD. Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo. J Exp Med 2000;192:1637-1644
14. Al Badri AM, Foulis AK, Todd PM, Gariouch JJ, Gudgeon JE, Stewart DG, Gracie JA, Goudie RB. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. J Pathol 1993;169:203-206
15. Smit N, Le Poole I, van den Wijngaard R, Tigges A, Westerhof W, Das P. Expression of different immunological markers by cultured human melanocytes. Arch Dermatol Res 1993;285:356-365
16. Yohn JJ, Critelli M, Lyons MB, Norris DA. Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. J Invest Dermatol 1990;90:233-237
17. Swope VB, Sauder DN, McKenzie RC, Sramkoski RM, Krug KA, Babcock GF, Nordlund JJ, Abdel-Malek ZA. Synthesis of interleukin-1α and β by normal human melanocytes. J Invest Dermatol 1994;102:749-753
18. Zachariae CO, Thestrup-Pedersen K, Matsushima K. Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells. J Invest Dermatol 1991;97:593-599
19. Le Poole IC, Boyce ST. Keratinocytes suppress transforming growth factor-betal expression by fibroblasts in cultured skin substitutes. Br J Dermatol 1999;140:409-416
20. Trautinger F, Kock A, Schauer E, Urbanski A, Schwarz T, Luger TA. Melanotropic hormones regulate cytokine production in normal human melanocytes (Abstract). Fifth Immunodermatology Symp Szeged, Hungary. Exp Dermatol 1992;1:95
21. Le Poole IC, van den Wijingaard RM, Westerhof W, Ottenhoff T, de Vries RR, Das PK. A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J Immunol 1993;151:7284-7292
22. Eisinger M, Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 1982;79:2018-2022
23. Shi HZ, Huang WD, Wang TD, Lu Y, Jiang Y, Zhang XG. Expression of human soluble CD40 ligand in Pichia pastoris and its effects on dendritic cells and malignant B cells. Acta Biochim et Biophys Sinica 2000;32:562-568
24. Kato K, Takaue Y, Wakasugi H. T cell-conditioned medium efficiently induces the maturation and function of human dendritic cells. J Leukoc Biol 2001;70:941-949
25. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000;67:2-16
26. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S, CD40 antigen and its ligand. Ann Rev Immunol 1994;12:881-922
27. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994;180:1263-1272
28. Peguet-Navarro J, Dalbiez-Gauthier C, Rattis FM, Van Kooten C, Banchereau J, Schmitt D. Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol 1995;155:4241-4247
29. Denfeld RW, Hollenbaugh D, Fehrenbach A, Weiss JM, von Leoprechting A, Mai B, Voith U, Schopf E, Aruffo A, Simon JC. CD40 is functionally expressed on human keratinocytes. Eur J Immunol 1996;26:2329-2334
30. Poudrier J, Owens T. CD54/intercellular adhesion molecule 1 and major histocompatibility complex 11 signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation. J Exp Med 1994;179:1417-1427
31. Norris DA, Lyons MB, Middleton MH, Yohn JJ, Kashihara-Sawami M. Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule-1 (ICAM-1) on the surface of cultured human keratinocytes. J Invest Dermatol 1990;95:132-138
32. Abraham D, Lupoli S, McWhirter A, Plater-Zyberk C, Piela TH, Korn JH, Olsen I, Black C. Expression and function of surface antigens on scleroderma fibroblasts. Arthritis Rheum 1991;34:1164-1172
33. Lawson C, Ainsworth M, Yacoub M, Rose M. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-kappa B-independent mechanism. J Immunol 1999;162:2990-2996
34. Tsujisaki M, Igarashi K, Eisinger M, Herlyn M, Ferrone S. Immunochemical and functional analysis of HLA class II antigens by recombinant immune interferon on normal human melanocytes. J Immunol 1987;138:1310-1316
35. Temponi M, Romano G, D'Urso CM, Wang Z, Kekish U, Ferrone S. Profile of intercellular adhesion molecule-1 (ICAM-1) synthesized by human melanoma cell lines. Semin Oncol 1988;15:595-607
36. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 1995;155:4917-4925
37. Pinchuk LM, Polacino PS, Agy MB, Klaus SJ, Clark EA. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1994;1:317-325
38. Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40. Science 1996;273:1862-1864
39. Stout RD, Suttles J. The many roles of CD40 in the cell mediated inflammatory responses. Immunol Today 1996;17:487-492
40. Grewal IS, Flavell RA. A central role of CD40 ligand in the regulation of CD4+ T cell responses. Immunol Today 1996;17:410-414
41. Dongari-Bagtzoglou AI, Warren WD, Berton MT, Ebersole JL. CD40 expression by gingival fibroblasts: Correlation of phenotype with function. Int Immunol 1997;9:1233-1241
42. Wagner AH, Gebauer M, Pollok-Kopp B, Hecker M. Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1. Blood 2002;99:520-525
43. Gaspari AA, Sempowski GD, Chess P, Gish J, Phipps RP. Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism. Eur J Immunol 1996;26:1371-1377
44. Pirozzi G, Lombari V, Zanzi D, Ionna F, Lombardi ML, Errico S, Ruggiero G, Manzo C. CD40 expressed on human melanoma cells mediates T cell growth co-stimulation and tumor growth. Int Immunol 2000;12:787-795
45. Van den Oord JJ, Maes A, Stas M, Nuyts J, Battocchio S, Kasran A, Garmyn M, De Wever I. CD40 is a prognostic marker in primary cutaneous malignant melanoma. Am J Pathol 1996;149:1953-1961
46. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993;178:669-674
47. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 1993;150:3671-3680
48. Galy AH, Spits H. CD40 is functionally expressed on human thymic epithelial cells. J Immunol 1992;149:775-782
49. Fries KM, Sempowski GD, Gaspari AA, Blieden T, Looney RJ, Phipps RP. CD40 expression by human fibroblasts. Clin Immunol Immunopathol 1995;77:42-51
50. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252
51. Husmann LA, Bevan MJ. Cooperation between helper T cells and cytotoxic T lymphocyte precursors. Ann N Y Acad Sci 1988;532:158-169
52. Bennett SR, Carbone PR, Karamalis F, Miller JF, Heath WR. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 1997;186: 65-70
53. Keene JA, Forman J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 1982;155:768-782
54. van Essen D, Kikutani H, Gray D. CD 40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995;378:620-623
55. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E, Romani N, Schuler G. High level IL-12 production by murine dendritic cells: Up-regulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1998;184:741-746
56. Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 1996;156:8-11
57. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G, Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1998;184:747-752
58. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998;393:480-483
59. Ridge JP, Rosa FD, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998;393:474-477